Funding of science
This article needs additional citations for verification. (February 2007)
|Part of a series on|
Research funding is a term generally covering any funding for scientific research, in the areas of natural science, technology, and social science. The term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and only the most promising receive funding.
Most research funding comes from two major sources, corporations (through research and development departments) and government (primarily carried out through universities and specialized government agencies; often known as research councils). A smaller amount of scientific research is funded by charitable foundations, especially in relation to developing cures for diseases such as cancer, malaria, and AIDS.[ citation needed]
Comparatively, in countries with less GDP such as Portugal and Mexico, the industry contribution is significantly lower. The government funding proportion in certain industries is higher, and it dominates research in social science and humanities. In commercial research and development, all but the most research-oriented corporations focus more heavily on near-term commercialization possibilities rather than "blue-sky" ideas or technologies (such as nuclear fusion). 
Wealth was created on farms growing food. The fecundity of the earth was seen to deteriorate over years of harvests so attention was given to restoring yields. Institutionalization of this study led to demonstration farms and then agricultural experiment stations. Germany and Connecticut saw early investment of government money into science to improve their economies, and ultimately research into agricultural chemistry.
In the eighteenth and nineteenth centuries, as the pace of technological progress increased before and during the industrial revolution, most scientific and technological research was carried out by individual inventors using their own funds. A system of patents was developed to allow inventors a period of time (often twenty years) to commercialise their inventions and recoup a profit, although in practice many found this difficult. The talents of an inventor are not those of a businessman, and there are many examples of inventors (e.g. Charles Goodyear) making rather little money from their work whilst others were able to market it.[ citation needed]
In the twentieth century, scientific and technological research became increasingly systematised, as corporations developed, and discovered that continuous investment in research and development could be a key element of success in a competitive strategy. It remained the case, however, that imitation by competitors - circumventing or simply flouting patents, especially those registered abroad - was often just as successful a strategy for companies focused on innovation in matters of organisation and production technique, or even in marketing. A classic example is that of Wilkinson Sword and Gillette in the disposable razor market, where the former has typically had the technological edge, and the latter the commercial one.[ citation needed]
Different countries spend vastly different amounts on research, in both absolute and relative terms. For instance, South Korea spends more than 4% of their GDP on research while many less developed countries spend less than 1% (e.g. GDP Spending on R&D 0.25%). 
The US spent $456.1 billion for research and development (R&D) in 2013, the most recent year for which such figures are available, according to the National Science Foundation. The private sector accounted for $322.5 billion, or 71%, of total national expenditures, with universities and colleges spending $64.7 billion, or 14%, in second place. 
Switzerland spent CHF 22 billion for R&D in 2015 with an increase of 10.5% compared with 2012 when the last survey was conducted.  In relative terms, this represents 3.4% of the country's GDP. R&D activities are carried out by nearly 125,000 individuals, mostly in the private sector (71%) and higher education institutions (27%).
Often scientists apply for research funding which a granting agency may (or may not) approve to financially support. These grants require a lengthy process as the granting agency can inquire about the researcher(s)'s background, the facilities used, the equipment needed, the time involved, and the overall potential of the scientific outcome. The process of grant writing and grant proposing is a somewhat delicate process for both the grantor and the grantee: the grantors want to choose the research that best fits their scientific principles, and the individual grantees want to apply for research in which they have the best chances but also in which they can build a body of work towards future scientific endeavors.[ citation needed]
The Engineering and Physical Sciences Research Council in the United Kingdom has devised an alternative method of fund-distribution: the sandpit. 
Most universities have research administration offices to facilitate the interaction between the researcher and the granting agency.  "Research administration is all about service—service to our faculty, to our academic units, to the institution, and to our sponsors. To be of service, we first have to know what our customers want and then determine whether or not we are meeting those needs and expectations." 
In the United States of America, the National Council of University Research Administrators (NCURA) serves its members and advances the field of research administration through education and professional development programs, the sharing of knowledge and experience, and by fostering a professional, collegial, and respected community.
Research councils are (usually public) bodies that provide research funding in the form of research grants or scholarships. These include arts councils and research councils for the funding of science.
An incomplete list of national and international pan-disciplinary public research councils:
Private funding for research comes from philanthropists,  crowd-funding,  private companies, non-profit foundations, and professional organizations.  Philanthropists and foundations have been known to pour millions of dollars into a wide variety of scientific investigations, including basic research discovery, disease cures, particle physics, astronomy, marine science, and the environment.  Many large technology companies spend billions of dollars on research and development each year to gain an innovative advantage over their competitors, though only about 42% of this funding goes towards projects that are considered substantially new, or capable of yielding radical breakthroughs.  New scientific start-up companies initially seek funding from crowd-funding organizations, venture capitalists, and angel investors, gathering preliminary results using rented facilities,  but aim to eventually become self-sufficient.  
In academic contexts, hard money may refer to funding received from a government or other entity at regular intervals, thus providing a steady inflow of financial resources to the beneficiary. The antonym, soft money, refers to funding provided only through competitive research grants and the writing of grant proposals. 
Hard money is usually issued by the government for the advancement of certain projects or for the benefit of specific agencies. Community healthcare, for instance, may be supported by the government by providing hard money. Since funds are disbursed regularly and continuously, the offices in charge of such projects are able to achieve their objectives more effectively than if they had been issued one-time grants.
Individual jobs at a research institute may be classified as "hard-money positions" or "soft-money positions";  the former are expected to provide job security because their funding is secure in the long term, whereas individual "soft-money" positions may come and go with fluctuations in the number of grants awarded to the institution.
The source of funding may introduce conscious or unconscious biases into a researcher's work.  Disclosure of potential conflicts of interest (COIs) is used by biomedical journals to guarantee credibility and transparency of the scientific process. Conflict of interest disclosure, however, is not systematically nor consistently dealt with by journals which publish scientific research results. When research is funded by the same agency that can be expected to gain from a favorable outcome there is a potential for biased results and research shows that results are indeed more favorable than would be expected from a more objective view of the evidence. A 2003 systematic review studied the scope and impact of industry sponsorship in biomedical research. The researchers found financial relationships among industry, scientific investigators, and academic institutions widespread. Results showed a statistically significant association between industry sponsorship and pro-industry conclusions and concluded that "Conflicts of interest arising from these ties can influence biomedical research in important ways".  A British study found that a majority of the members on national and food policy committees receive funding from food companies. 
In an effort to cut costs, the pharmaceutical industry has turned to the use of private, nonacademic research groups (i.e., contract research organizations [CROs]) which can do the work for less money than academic investigators. In 2001 CROs came under criticism when the editors of 12 major scientific journals issued a joint editorial, published in each journal, on the control over clinical trials exerted by sponsors, particularly targeting the use of contracts which allow sponsors to review the studies prior to publication and withhold publication of any studies in which their product did poorly. They further criticized the trial methodology stating that researchers are frequently restricted from contributing to the trial design, accessing the raw data, and interpreting the results. 
The Cochrane Collaboration, a worldwide group that aims to provide compiled scientific evidence to aid well informed health care decisions, conducts systematic reviews of randomized controlled trials of health care interventions and tries to disseminate the results and conclusions derived from them.   A few more recent reviews have also studied the results of non-randomized, observational studies. The systematic reviews are published in the Cochrane Library. A 2011 study done to disclose possible conflicts of interests [COI] in underlying research studies used for medical meta-analyses reviewed 29 meta-analyses and found that COIs in the studies underlying the meta-analyses were rarely disclosed. The 29 meta-analyses reviewed an aggregate of 509 randomized controlled trials (RCTs). Of these, 318 RCTs reported funding sources with 219 (69%) industry funded. 132 of the 509 RCTs reported author COI disclosures, with 91 studies (69%) disclosing industry financial ties with one or more authors. The information was, however, seldom reflected in the meta-analyses. Only two (7%) reported RCT funding sources and none reported RCT author-industry ties. The authors concluded "without acknowledgement of COI due to industry funding or author industry financial ties from RCTs included in meta-analyses, readers' understanding and appraisal of the evidence from the meta-analysis may be compromised." 
In 2003 researchers looked at the association between authors' published positions on the safety and efficacy in assisting with weight loss of olestra, a fat substitute manufactured by the Procter & Gamble (P&G), and their financial relationships with the food and beverage industry. They found that supportive authors were significantly more likely than critical or neutral authors to have financial relationships with P&G and all authors disclosing an affiliation with P&G were supportive. The authors of the study concluded: "Because authors' published opinions were associated with their financial relationships, obtaining noncommercial funding may be more essential to maintaining objectivity than disclosing personal financial interests." 
A 2005 study in the journal Nature  surveyed 3247 US researchers who were all publicly funded (by the National Institutes of Health). Out of the scientists questioned, 15.5% admitted to altering design, methodology or results of their studies due to pressure of an external funding source.
Most funding agencies mandate efficient use of their funds; they want to maximize outcome for their money spent. Outcome can be measured by publication output, citation impact, number of patents, number of PhDs awarded etc. Another question is how to allocate funds to different disciplines, institutions, or researchers. A recent study by Wayne Walsh found that “prestigious institutions had on average 65% higher grant application success rates and 50% larger award sizes, whereas less-prestigious institutions produced 65% more publications and had a 35% higher citation impact per dollar of funding.”  
- Scientific funding advisory bodies (category)
- Funding bias
- Science policy
- Self-Organized Funding Allocation
- Industry funding of academic research
- OECD Science, Technology and Industry Scoreboard 2015: Innovation for growth and society. OECD Science, Technology and Industry Scoreboard. OECD. 2015. p. 156. doi: 10.1787/sti_scoreboard-2015-en. ISBN 9789264239784 – via oecd-ilibrary.org.
- Taylor, R.A. (2012). "Socioeconomic impacts of heat transfer research". International Communications in Heat and Mass Transfer. 39 (10): 1467–1473. doi: 10.1016/j.icheatmasstransfer.2012.09.007.
"Gross domestic spending on R&D (indicator)". 2017-06-06.
10.1787/d8b068b4-en. Retrieved 1 July 2017. Cite journal requires
- Boroush, Mark (September 2015). "U.S. R&D Increased in 2013, Well Ahead of the Pace of Gross Domestic Product" (PDF). National Science Foundation InfoBrief. Retrieved July 22, 2019.
- "Recherche et développement en Suisse 2015 (press release)". 2017-05-29. Retrieved 1 July 2017.
Corbyn, Zoë (2009-07-02).
"'Sandpits' bring out worst in 'infantilised' researchers". Times Higher Education. TSL Education.
Sandpits, which were devised by the Engineering and Physical Sciences Research Council, typically involve about 30 selected researchers from different areas who are brought together for several days of intensive discussions about a particular topic. [...] The wheels of such events are oiled with the promise of up to £1 million in funding, which is dished out at the end through a group peer-review process.
- Gonzales, Evelina Garza, "External Funding and Tenure at Texas State University-San Marcos" (2009). Texas State University. Applied Research Projects. Paper 315. http://ecommons.txstate.edu/arp/315
- Robert A. Killoren Jr., Associate Vice President for Research, Office of Sponsored Programs, Penn State U, Fall 2005. From Lowry, Peggy (2006) "Assessing the Sponsored Research Office". SPONSORED RESEARCH ADMINISTRATION: A Guide to Effective Strategies and Recommended Practices Archived 2009-04-22 at the Wayback Machine
- "Danish Agency for Science, Technology and Innovation".
- "RANNIS (Icelandic Centre for Research)". Rannis.is.
- "Israel Science Foundation". Archived from the original on 2015-12-16.
- "The Uganda National Council for Science and Technology - UNCST".
- William J. Broad (2014-03-15). "Billionaires With Big Ideas Are Privatizing American Science". The New York Times. Retrieved 30 November 2014.
- Giles, Jim (2012). "Finding philanthropy: Like it? Pay for it". Nature. 481 (7381): 252–253. Bibcode: 2012Natur.481..252G. doi: 10.1038/481252a. PMID 22258587.
- "Possible Funding Sources".
- Jaruzelski, B.; V. Staack; B. Goehle (2014). Global Innovation 1000: Proven Paths to Innovation Success (Technical report). Strategy&.
- Stephanie M. Lee (27 August 2014). "New Palo Alto lab for life science startups". SFGate.
- Dharmesh Shah. "7 Lessons On Startup Funding From a Research Scientist".
- "What is a soft-money research position?", Academia StackExchange
- "Who pays for science?".
- Lenard I Lesser; Cara B Ebbeling; Merrill Goozner; David Wypij; David S Ludwig (January 9, 2007). "Relationship between Funding Source and Conclusion among Nutrition-Related Scientific Articles". PLOS Medicine. PLOS. 4 (1): e5. doi: 10.1371/journal.pmed.0040005. PMC 1764435. PMID 17214504.
- Marion Nestle (October 2001). "Food company sponsorship of nutrition research and professional activities: a conflict of interest?". Public Health Nutrition. Cambridge University Press. 4 (5): 1015–1022. doi: 10.1079/PHN2001253. PMID 11784415.
- Davidoff, F; Deangelis, C. D.; Drazen, J. M.; Nicholls, M. G.; Hoey, J; Højgaard, L; Horton, R; Kotzin, S; Nylenna, M; Overbeke, A. J.; Sox, H. C.; Van Der Weyden, M. B.; Wilkes, M. S. (September 2001). "Sponsorship, authorship and accountability". CMAJ. 165 (6): 786–8. PMC 81460. PMID 11584570.
- Scholten, R. J.; Clarke, M; Hetherington, J (August 2005). "The Cochrane Collaboration". Eur J Clin Nutr. Suppl 1. 59 (S1): S147–S149. doi: 10.1038/sj.ejcn.1602188. PMID 16052183.
- "How Well Do Meta-Analyses Disclose Conflicts of Interests in Underlying Research Studies". The Cochrane Collaboration website. Cochrane Collaboration. 2011-06-06. Retrieved 24 March 2014.
- Levine, J; Gussow, JD; Hastings, D; Eccher, A (2003). "Authors' Financial Relationships With the Food and Beverage Industry and Their Published Positions on the Fat Substitute Olestra". American Journal of Public Health. 93 (4): 664–9. doi: 10.2105/ajph.93.4.664. PMC 1447808. PMID 12660215.
- Martinson, BC; Anderson, MS; De Vries, R (2005). "Scientists behaving badly". Nature. 435 (7043): 737–8. Bibcode: 2005Natur.435..737M. doi: 10.1038/435737a. PMID 15944677. S2CID 4341622.
- Fang, H. (2011). "Peer review and over-competitive research funding fostering mainstream opinion to monopoly". Scientometrics. 87 (2): 293–301. doi: 10.1007/s11192-010-0323-4. S2CID 24236419.
- "Research Dollars Go Farther at Less-Prestigious Institutions: Study". The Scientist Magazine®. Retrieved 2018-07-23.
- Wahls, Wayne P. (2018-07-13). "High cost of bias: Diminishing marginal returns on NIH grant funding to institutions". bioRxiv: 367847. doi: 10.1101/367847.
- Eisfeld-Reschke, Jörg, Herb, Ulrich, & Wenzlaff, Karsten (2014). Research Funding in Open Science. In S. Bartling & S. Friesike (Eds.), Opening Science (pp. 237–253). Heidelberg: Springer. doi: 10.1007/978-3-319-00026-8_16
- Herb, Ulrich (2014-07-31). "Open science's final frontier". Research Europe Magazine. Archived from the original on 2014-09-03. Retrieved 2014-08-30.
- Martinson, Brian C.; De Vries, Raymond; et al. (2005). "Scientists behaving badly". Nature. 435 (7043): 737–738. Bibcode: 2005Natur.435..737M. doi: 10.1038/435737a. PMID 15944677. S2CID 4341622.
- Mello, Michelle M.; et al. (2005). "Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry". New England Journal of Medicine. 352 (21): 2202–2210. doi: 10.1056/nejmsa044115. PMID 15917385. S2CID 8283797.
- Odlyzko, Andrew (1995-10-04). "The Decline of Unfettered Research". Retrieved 2007-11-02.
- Where to Search for Funding | Science | AAAS, from Science Careers, from the Journal Science.
- ResearchCrossroads Aggregated funding data from NIH, NSF, private foundations and EU
- Seventh Framework Programme (2007–2013) The European Unions's programme for funding and promoting research at the European level
- CORDIS - the official website of the European Unions's programme for funding and promoting research This website contains comprehensive information on research projects already funded.
- Research Councils UK The portal for the UK-based Research Councils.